Myrotx
Boston, US · 1 known investors
Find your way into Myrotx
Myrobalan Therapeutics is a pre-clinical biotech company developing small molecule therapies targeting microglia and oligodendrocytes to address neurodegeneration and demyelinating disorders. The company's precision medicines aim to promote remyelination and reduce neuroinflammation in conditions such as multiple sclerosis, Alzheimer's disease, and ALS.
Founders & leadership
JW
Jing Wang, PhDCo-Founder & CEO
GF
Guoping Feng, PhDScientific Co-Founder
ZH
Zhigang HeScientific Co-founder
GF
Guoping FengScientific Co-founder
Investors · 1
Frequently asked questions
- What does Myrotx do?
- Myrobalan Therapeutics is a pre-clinical biotech company developing small molecule therapies targeting microglia and oligodendrocytes to address neurodegeneration and demyelinating disorders. The company's precision medicines aim to promote remyelination and reduce neuroinflammation in conditions such as multiple sclerosis, Alzheimer's disease, and ALS.
- Who founded Myrotx?
- Myrotx was founded by Jing Wang, PhD, Guoping Feng, PhD, Zhigang He, Guoping Feng.
- Who are Myrotx's investors?
- Myrotx's investors include 3E Bioventures Capital.
- Where is Myrotx headquartered?
- Myrotx is headquartered in Boston, US.